Control Biologic Rx Costs

Dermatology Specialty Drugs: Costing your plan millions & counting

Psoriasis & eczema drugs are an expensive and growing problem. Access millions in same-year returns deprescribing your highest-cost members with a >3:1 ROI guarantee.

Cut My Specialty Spend
State of Psoriasis & Eczema in U.S.
Nearly 10% of the population has eczema or psoriasis
Biologics make up 2% of prescriptions, 37% of net drug spend
Specialty dermatology spend is growing 46% YoY
77% of dermatologists extremely comfortable starting a member on a biologic early
50%+ on high-cost therapies could benefit from dose reduction
Health plan biologic spend per member per month is up 24%
Dermatology Biologic Cost Control

Impact Rx costs and improve outcomes

Health Plans, PBMs, & Payers: target your highest-cost and highest-risk members to curb the biologic spend.

Biologic spend on psoriasis and eczema in 2025*

*IQVIA. (2026, April). Healthcare & pharmaceutical marketplace trends

Specialty drugs for psoriasis & eczema are 5 of the top 10 fastest growing drugs, growing by >$24B in 2025 and representing >$78B in total spend.

Decrease My Spend

Trusted by both national and regional health plans across the country, access:

Predictable savings
Accountable to the payer and the members
Remission-centered cost control

Access Right-Sized Care In Step with your formulary only with Zest Health

Member-Driven Rx Drug Cost Skyrockets

Utilization growth driving millions in unnecessary specialty dermatology drug spend

Specialty drugs meant for only the most severe cases are approved and now widely prescribed for moderate disease, too. Utilization growth is driven in part by consumer demand from heavy D2C advertising and traditional dermatologists who are quick to prescribe specialty drugs and know how to get them approved.

33%
Reduction in pharmacy drug spend
$37M
Savings per 1 million lives
>3:1
Return on investment

Discover how much you could save with Zest

Many of our partners are surprised to learn just how much they’re spending on biologics for dermatology care – and how much of that spending may not be necessary.

Biologic spending has increased at a compound annual growth rate of 10% from 2014-2024. This is often aggregated in a small identifiable group of high-cost members.

See exactly how much you’ll save – based on your own claims data.

ROI Calculator

How many members do you provide health insurance for?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

We estimate you are spending

-$
0
/yr

on biologics for Eczema and Psoriasis.

With Zest, up to

+$
0
/yr

can be avoided while improving access and patient outcomes.

Let's work together

Trusted by 20M+ members of national and regional health plans across the country, Zest Health is committed to improving outcomes and decreasing reliance on specialty drugs for psoriasis and eczema. Proactively right-size what is one of the fastest-growing categories of specialty drug spend by contacting us today.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By submitting the form, I agree to Zest's Terms and Policies.